Approval · Notice of Compliance 19699 · 2017
CONRAY 30: Notice of Compliance 19699
Issued August 23, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19699
- Date
- August 23, 2017
- Company
- Liebel-Flarsheim Canada IncPointe-Claire, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To improve the safety information in the product mnograph for conray in response to health canada's class labelling change request for all iodine-based contrast media with respect to thyroid dysfunction
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CONRAY 30 | Not yet assigned | — |
| CONRAY 43 | Not yet assigned | — |
| CONRAY 60 | Not yet assigned | — |
Medicinal ingredients
- IOTHALAMATE MEGLUMINE 231.8 MG per ML
- IOTHALAMATE MEGLUMINE 331.8 MG per ML
- IOTHALAMATE MEGLUMINE 462 MG per ML